Showing results (1331-1340 of 1,800) with videos related to

Sort By:
Pageof 180
Arthritis and Rheumatism|January 3, 2013
AA amyloidosis complicating the hereditary periodic fever syndromesThirusha Lane, Jutta M Loeffler, Dorota M Rowczenio, et al.
Gesundheitswesen (Bundesverband Der Arzte Des Offentlichen Gesundheitsdienstes (Germany))|June 9, 2020
[An Update on the Epidemiological Situation of Alveolar Echinococcosis: Recording and Reporting Structures in Austria, Switzerland and Germany]Julian Schmidberger, Sven Baumann, Wolfgang Kratzer, et al.
Annals of Intensive Care|April 26, 2021
Circadian rhythms in septic shock patientsGunnar Lachmann, Bharath Ananthasubramaniam, Viktor A Wünsch, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|February 13, 2013
Movement disorders in adult patients with classical galactosemiaIgnacio Rubio-Agusti, Miryam Carecchio, Kailash P Bhatia, et al.
Haematologica|August 11, 2019
Cardiac biomarkers are prognostic in systemic light chain amyloidosis with no cardiac involvement by standard criteriaFaye A Sharpley, Marianna Fontana, Ana Martinez-Naharro, et al.
Clinical, Cosmetic and Investigational Dermatology|March 3, 2026
Concomitant Use of Dermo-Cosmetic Skin Care in Aesthetic Procedures: Systematic Review with Expert Panel RecommendationsAndreas Nikolis, Mark S Nestor, Joanna Czuwara, et al.
Journal of Applied Physiology (Bethesda, Md. : 1985)|February 14, 2002
Biopsy coupled to quantitative immunofluorescence: a new method to study the human vascular endotheliumPaolo C Colombo, Anthony W Ashton, Sulejman Celaj, et al.
Pediatric Rheumatology Online Journal|March 23, 2018
The safety of live-attenuated vaccines in patients using IL-1 or IL-6 blockade: an international surveyJerold Jeyaratnam, Nienke M Ter Haar, Helen J Lachmann, et al.
International Journal of Cardiology|August 9, 2018
Reducing late maternal death due to cardiovascular disease - A pragmatic pilot studyKaren Sliwa, Feriel Azibani, Johann Baard, et al.
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|May 22, 2023
A phase 1b dose-escalation study of carfilzomib in combination with thalidomide and dexamethasone in patients with relapsed/refractory systemic immunoglobulin light chain amyloidosisSriram Ravichandran, Andrew Hall, Matthew Jenner, et al.
Pageof 180